Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc.

No trades
See on Supercharts
Market capitalization
‪290.58 M‬USD
−1.46USD
‪−67.00 M‬USD
‪5.12 M‬USD
‪25.45 M‬
Beta (1Y)
2.16

About Verrica Pharmaceuticals Inc.

CEO
Ted White
Headquarters
West Chester
Employees (FY)
100
Founded
2013
FIGI
BBG00L03BYB7
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VRCA is 6.79 USD — it has decreased by 0.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Verrica Pharmaceuticals Inc. stocks are traded under the ticker VRCA.
Verrica Pharmaceuticals Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
VRCA stock is 3.16% volatile and has beta coefficient of 2.16. Check out the list of the most volatile stocks — is Verrica Pharmaceuticals Inc. there?
VRCA earnings for the last quarter are −0.54 USD per share, whereas the estimation was −0.36 USD resulting in a −49.44% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Verrica Pharmaceuticals Inc. earnings.
Verrica Pharmaceuticals Inc. revenue for the last quarter amounts to ‪2.92 M‬ USD despite the estimated figure of ‪454.07 K‬ USD. In the next quarter revenue is expected to reach ‪975.25 K‬ USD.
Yes, you can track Verrica Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
VRCA stock has fallen by 3.69% compared to the previous week, the month change is a 34.19% rise, over the last year Verrica Pharmaceuticals Inc. has showed a 4.30% increase.
VRCA net income for the last quarter is ‪−24.61 M‬ USD, while the quarter before that showed ‪−24.80 M‬ USD of net income which accounts for 0.76% change. Track more Verrica Pharmaceuticals Inc. financial stats to get the full picture.
Today Verrica Pharmaceuticals Inc. has the market capitalization of ‪288.03 M‬, it has decreased by 3.00% over the last week.
No, VRCA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VRCA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Verrica Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
VRCA reached its all-time high on Jun 20, 2018 with the price of 23.29 USD, and its all-time low was 1.77 USD and was reached on Jun 1, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 100.00 employees. See our rating of the largest employees — is Verrica Pharmaceuticals Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Verrica Pharmaceuticals Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Verrica Pharmaceuticals Inc. stock shows the buy signal. See more of Verrica Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Verrica Pharmaceuticals Inc. future price: according to them, VRCA price has a max estimate of 22.00 USD and a min estimate of 8.00 USD. Read a more detailed Verrica Pharmaceuticals Inc. forecast: see what analysts think of Verrica Pharmaceuticals Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Verrica Pharmaceuticals Inc. EBITDA is ‪−62.39 M‬ USD, and current EBITDA margin is ‪−1.22 K‬%. See more stats in Verrica Pharmaceuticals Inc. financial statements.